American Society of Hematology 2022

American Society of Hematology 2022
December 10-13, 2022
New Orleans, LA

American Society of Hematology 2022.

Explore more information for Gilead Oncology therapies
Results (2)

Magrolimab in Combination With Rituximab + Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Nature of Clinical Response and Depth of Molecular Response in Patients with TP53 Mutant Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Treated with Magrolimab with Azacitidine